Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The acetylcholine (ACh) release machinery encompasses the molecular components responsible for the synthesis, storage, regulated release, and breakdown of acetylcholine at cholinergic nerve terminals. Key components include choline acetyltransferase (ChAT) for ACh synthesis, vesicular acetylcholine transporter (VAChT) for storage, SNARE proteins and synaptotagmin for calcium-dependent exocytosis, nicotinic and muscarinic receptors for postsynaptic signaling, and acetylcholinesterase (AChE) for ACh breakdown. The machinery is crucial for neuromuscular transmission, autonomic functions, and cognitive processes, and is a target for drugs treating conditions like myasthenia gravis and Alzheimer's disease.
Modulation of acetylcholine levels and receptor activity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine Release Machinery (None).